Bcl-2-associated death promoter

From WikiMD's WELLNESSPEDIA

Bcl-2-associated death promoter (BAD) is a pro-apoptotic member of the Bcl-2 family of proteins. It plays a crucial role in the regulation of apoptosis, a form of programmed cell death, by promoting cell death in response to various cellular stress signals.

Structure[edit]

BAD is a member of the Bcl-2 family, which is characterized by the presence of one or more Bcl-2 homology domains (BH domains). BAD contains the BH3 domain, which is essential for its pro-apoptotic activity. The BH3 domain allows BAD to interact with and neutralize anti-apoptotic proteins such as Bcl-2 and Bcl-xL, thereby promoting apoptosis.

Function[edit]

BAD promotes apoptosis by binding to and inhibiting the function of anti-apoptotic Bcl-2 family members. This interaction releases pro-apoptotic factors such as Bax and Bak, which then oligomerize and form pores in the mitochondrial outer membrane. This leads to the release of cytochrome c and other pro-apoptotic factors from the mitochondria into the cytosol, triggering the activation of caspases and the execution of apoptosis.

Regulation[edit]

The activity of BAD is regulated by phosphorylation. When BAD is phosphorylated by kinases such as Akt or Protein kinase A, it is sequestered in the cytosol by binding to 14-3-3 proteins, which prevents it from interacting with Bcl-2 and Bcl-xL. Dephosphorylation of BAD, on the other hand, allows it to translocate to the mitochondria and promote apoptosis.

Clinical Significance[edit]

Dysregulation of BAD and other Bcl-2 family members is implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Overexpression of anti-apoptotic Bcl-2 family proteins can lead to resistance to apoptosis, contributing to the survival and proliferation of cancer cells. Conversely, enhancing the pro-apoptotic activity of BAD is being explored as a potential therapeutic strategy for inducing cell death in cancer cells.

See Also[edit]

References[edit]


External Links[edit]

-

Template:Apoptosis-stub

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Bcl-2-associated_death_promoter&oldid=5795143"